기사

[Vegan News = Reporter Lee Yong-hak] 

Prodizen is the first company in Korea to develop and sell PRP, has passed various new medical technologies in the PRP field, and is a global cell therapy company certified by the U.S. FDA, China's CFDA, and CE.

The newly launched Bone Marrow Concentrate (BMC) KIT is a technology that extracts bone marrow from a patient's iliac crest, puts it in a dedicated product, and concentrates it to extract bone marrow aspiration concentrations. It is currently an injection treatment that has passed the New Medical Technology (Ministry of Health and Welfare No. 2023-128) and can be injected into patients with knee osteoarthritis.

Officials explain that Prodizen bone marrow KIT can accurately extract bone marrow aspiration concentrations and inject them into the knee using its own technology that has already been recognized worldwide in the PRP field.

CEO Shim Soo-ja said, "As a leading company in the field of cell therapy and tissue regeneration engineering, we are constantly developing new technologies through continuous research. We will continue to strive to become a leader in the bio industry worldwide beyond Korea in the future," he said.